Ionene polymers and their use as antimicrobial agents
View Patent ↗Disclosed are ionene polymers having antimicrobial activity. “Ionene polymers” as used in this invention are cationic polymers in which a substantial proportion of the atoms providing the positive charge are quaternized nitrogens located in the main polymeric chain or backbone of the polymer rather than in pendant groups. Also disclosed are antimicrobial compositions comprising ionene polymers and methods for treating microbial infections in mammals comprising the step of administering to a mammal, a therapeutically effective amount of at least one antimicrobial composition of the invention. Also disclosed are antimicrobial compositions comprising at least one ionene polymer and methods for preventing, inhibiting or eliminating the growth, dissemination, and/or the accumulation of microorganisms on a susceptible surface (including, but not limited to, the formation of biofilms on a susceptible surface) comprising the step of contacting such surface with a composition of the invention.
1. A polymer or copolymer characterized by a repeat unit having the formula:
wherein Y 1 and Y 2 are independently a lower alkylene or lower alkylene glycol group, provided that Y 2 is substituted with two or more alcohol groups; each X − ; separately or taken together, is a physiologically acceptable anion; and said polymer or copolymer is substantially free of diphenol.
2. The polymer of claim 1 , wherein said polymer is a homopolymer.
3. The polymer or copolymer of claim 1 wherein the polymer or copolymer is characterized by repeat units of formula XVI or XVII:
4. A pharmaceutical composition comprising a physiologically acceptable carrier or diluent and a polymer or copolymer characterized by a repeat unit having the formula:
wherein Y 1 and Y 2 are each independently a substituted or unsubstituted lower alkylene or lower alkylene glycol group; and each X − , separately or taken together, is a physiologically acceptable anion.
5. The pharmaceutical composition of claim 4 , wherein at least one lower alkylene or lower alkylene glycol group represented by Y 1 and Y 2 is substituted.
6. The pharmaceutical composition of claim 4 , wherein the polymer or copolymer is characterized by repeat units of formula XVI or XVII:
7. A method of treating a microbial infection in a mammal comprising the step of administering to said mammal a therapeutically effective amount of a polymer or copolymer of claim 1 .
8. A method of treating a microbial infection in a mammal comprising the step of administering to said mammal a therapeutically effective amount of a homopolymer of claim 2 .
9. A method of treating a microbial infection in a mammal comprising the step of administering to said mammal a therapeutically effective amount of a polymer or copolymer of claim 3 .
10. A method of treating a microbial infection in a mammal comprising the step of administering to said mammal a therapeutically effective amount of a pharmaceutical composition of claim 4 .
11. A method of treating a microbial infection in a mammal comprising the step of administering to said mammal a therapeutically effective amount of a pharmaceutical composition of claim 5 .
12. A method of treating a microbial infection in a mammal comprising the step of administering to said mammal a therapeutically effective amount of a pharmaceutical composition of claim 6 .
13. A method of inhibiting the growth of a microorganism on a surface comprising the step of contacting said surface with an effective amount of a polymer or copolymer of claim 1 .
14. A method of inhibiting the growth of a microorganism on a surface comprising the step of contacting said surface with an effective amount of a homopolymer of claim 2 .
15. A method of inhibiting the growth of a microorganism on a surface comprising the step of contacting said surface with an effective amount of a polymer or copolymer of claim 3 .
16. A pharmaceutical composition comprising a polymer or copolymer characterized by a repeat unit having the formula:
and a pharmaceutically acceptable carrier or diluent, wherein each X − , separately or taken together, is a pharmaceutically acceptable anion.
17. A method of treating a microbial infection in the gastrointestinal tract of a mammal comprising the step of administering to said mammal a therapeutically effective amount of a pharmaceutical composition of claim 16 .
18. A pharmaceutical composition comprising a polymer or copolymer characterized by a repeat unit having the formula:
and a pharmaceutically acceptable carrier or diluent, wherein each X − , separately or taken together, is a physiologically acceptable anion.
19. A method of treating a microbial infection of the oral mucosa or gastrointestinal tract of a mammal comprising the step of administering to said mammal a therapeutically effective amount of a pharmaceutical composition of claim 18 .
20. A copolymer characterized by a repeat unit having the formula:
wherein each X − , separately or taken together, is a physiologically acceptable anion.
21. A pharmaceutical composition comprising a polymer or copolymer characterized by a repeat unit having the formula:
and a pharmaceutically acceptable carrier or diluent, wherein each X − , separately or taken together, is a physiologically acceptable anion.
22. A method of treating a microbial infection in a mammal comprising the step of administering to said mammal a therapeutically effective amount of a copolymer of claim 20 .
23. A method of treating a microbial infection in a mammal comprising the step of administering to said mammal a therapeutically effective amount of a pharmaceutical composition of claim 21 .
24. A method of inhibiting the growth of a microorganism on a surface comprising the step of contacting said surface with an effective amount of a copolymer of claim 20 .
25. A pharmaceutical composition comprising a physiologically acceptable carrier or diluent and a polymer or copolymer characterized by a repeat unit having the formula:
wherein Y 1 and Y 2 are each independently a lower alkylene or lower alkylene glycol group, provided that Y 2 is substituted with two or more alcohol groups; and each X − , separately or taken together, is a physiologically acceptable anion.
26. A method of treating a microbial infection in a mammal comprising the step of administering to said mammal a therapeutically effective amount of a pharmaceutical composition of claim 25 .